What is PT-141 peptide used for? Learn about bremelanotide's FDA-approved use for low sexual desire in women, off-label uses, dosing, and side effects.
PT-141 (bremelanotide) is a prescription peptide used to treat acquired, generalized hypoactive sexual desire disorder (HSDD) in premenopausal women — a persistent lack of sexual interest that causes personal distress. It is sold under the brand name Vyleesi and is injected under the skin before anticipated sexual activity. Nothing else about PT-141 is FDA-approved, including tanning, athletic performance, or general libido boosting in healthy adults.
What PT-141 Is and How It Works
PT-141 is the research name for bremelanotide, a synthetic peptide that mimics alpha-melanocyte-stimulating hormone. It binds melanocortin receptors, mainly MC4R, in the hypothalamus — a brain region involved in desire, mood, and appetite regulation.
Because it acts on the central nervous system, PT-141 works differently from PDE5 inhibitors such as sildenafil. Those drugs increase blood flow; bremelanotide targets brain pathways tied to sexual interest. PT-141 contains no hormones and does not raise testosterone or estrogen levels.
The question what is pt-141 comes up often because the peptide is confused with Melanotan II, a related compound studied for skin darkening. Researchers derived PT-141 from Melanotan II after noticing that study participants reported unexpected increases in sexual interest.
What PT-141 Is Used For
The FDA approved bremelanotide in 2019 for one specific indication: acquired, generalized HSDD in premenopausal women. Every other use you see discussed online is off-label, experimental, or based on animal and early-stage human research.
| Use | Regulatory status | What the evidence shows |
|---|---|---|
| Low sexual desire (HSDD) in premenopausal women | FDA-approved as Vyleesi | Two phase 3 trials showed modest improvements in desire and distress |
| HSDD in postmenopausal women | Not approved | Trials did not show a meaningful benefit |
| Erectile dysfunction in men | Not approved | Small studies suggest a limited effect, sometimes combined with a PDE5 inhibitor |
| Skin tanning | Not approved | Studied only in early research on related compounds |
| General "libido booster" in healthy people | Not approved | No controlled data in people without a diagnosis |
Off-Label and Research Uses
Clinicians sometimes prescribe PT-141 off-label for men with erectile dysfunction who do not respond to standard treatments. The research base for this is small, and results have generally been modest.
Researchers have also explored melanocortin agonists for female sexual arousal disorder, delayed ejaculation, and appetite regulation. These areas remain experimental and are not part of routine medical practice.
PT-141 for Women and Men
Most clinical data on pt 141 peptide for women comes from premenopausal participants with a formal HSDD diagnosis, not from women looking for a general enhancement product. If you are wondering what is pt 141 good for in men, the honest answer is that it is not approved for any male indication and evidence is limited.
How PT-141 Is Dosed
Vyleesi is supplied as a single-use auto-injector that delivers 1.75 mg of bremelanotide. The standard instructions are straightforward:
- Inject under the skin of the abdomen or thigh.
- Use it at least 45 minutes before anticipated sexual activity.
- Do not use more than one dose in 24 hours.
- Do not use more than 8 doses in a month.
Nausea is the most common reason people stop using PT-141. Some clinicians recommend taking an anti-nausea medication 30 to 60 minutes before the injection to reduce that risk.
Unlike PDE5 inhibitors, bremelanotide has not shown a dangerous interaction with alcohol or nitrates. That does not make it risk-free, and it still requires a prescription and medical supervision.
Side Effects, Warnings, and Safety
Nausea affects roughly 40% of users in clinical trials, and it is usually the most bothersome effect. Other reported reactions include flushing, headache, vomiting, injection site reactions, and fatigue.
PT-141 can cause a temporary rise in blood pressure and heart rate. It is contraindicated in people with uncontrolled high blood pressure or known cardiovascular disease. Repeated use has also been linked to focal hyperpigmentation — dark patches on the skin, gums, or breasts.
Long-term safety data beyond several months of regular use is limited. Anyone considering PT-141 should discuss cardiovascular history, current medications, and pregnancy plans with a healthcare professional before starting.
How PT-141 Compares With Other Peptides
PT-141 is often discussed alongside other research peptides, even though their intended targets are completely different. People researching what is cjc 1295 ipamorelin used for, for example, are usually looking at growth hormone pathways rather than sexual function.
| Compound | Primary focus | US regulatory status |
|---|---|---|
| PT-141 (bremelanotide) | Low sexual desire in premenopausal women | FDA-approved, prescription only |
| CJC-1295 / Ipamorelin | Growth hormone research | Not approved for human use |
| Semax | Cognitive and neurological research | Not approved in the US |
| BPC-157 | Tissue repair research | Not approved for human use |
| Sildenafil (Viagra) | Erectile dysfunction | FDA-approved, prescription only |
One practical difference stands out: PT-141 is the only peptide in this group with an FDA-approved sexual health indication. The others are sold almost entirely as research chemicals.
Buying PT-141: Prescriptions, Research Chemicals, and Quality
PT-141 is a prescription drug in the United States. It is dispensed through specialty pharmacies as the Vyleesi auto-injector after a clinician evaluation.
Powdered “PT-141” sold by online vendors is generally labeled as a research chemical and is not intended for human use. These products are not reviewed by the FDA for identity, purity, or sterility, so dosing accuracy and contamination are real concerns.
If you are reading about reconstituting a lyophilized powder, you will likely see references to what is bacteriostatic water for injection used for — it is sterile water containing 0.9% benzyl alcohol that slows bacterial growth in multi-dose vials. It is a laboratory supply, not a substitute for pharmaceutical-grade preparation.
PT-141 is not a cure for low desire, and it does not address relationship, hormonal, psychological, or medication-related causes. A healthcare professional can help determine whether the diagnosis fits and whether an approved treatment is appropriate.
Frequently Asked Questions
Is PT-141 FDA-approved?
Yes, but only for one use. Bremelanotide was approved in 2019 under the brand name Vyleesi for acquired, generalized hypoactive sexual desire disorder in premenopausal women. It is not approved for men, for postmenopausal women, or as a general libido enhancer.
How long does PT-141 take to work?
PT-141 is injected at least 45 minutes before anticipated sexual activity, and many users report effects within that window. The medication is dosed no more than once in 24 hours and no more than 8 times per month.
Can you buy PT-141 over the counter?
No. PT-141 is a prescription medication in the United States and is dispensed as the Vyleesi auto-injector. Products sold online as “PT-141 research chemical” are not FDA-approved for human use and carry purity, sterility, and dosing risks.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.